Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Acute kidney failure

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    261 result(s) found for: Acute kidney failure. Displaying page 6 of 14.
    «« First « Previous 2  3  4  5  6  7  8  9  10  Next» Last»»
    EudraCT Number: 2019-002946-19 Sponsor Protocol Number: 1245-0204 Start Date*: 2020-01-15
    Sponsor Name:Boehringer Ingelheim
    Full Title: A multicentre, randomised, double-blind, 90-day superiority trial to evaluate the effect on clinical benefit, safety and tolerability of once daily oral EMPagliflozin 10 mg compared to placebo, ini...
    Medical condition: Heart Failure
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004849 10019279 Heart failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) NL (Completed) BE (Completed) DE (Completed) DK (Completed) ES (Completed) HU (Completed) PL (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2019-004243-74 Sponsor Protocol Number: CPRC2018/EVATRAN-GIRERD/JL Start Date*: 2020-06-02
    Sponsor Name:Centre Hospitalier Régional Universitaire de Nancy
    Full Title: A randomized crossover clinical trial regarding the blockage of the mineralocorticoid receptor using Eplerenone on the evolution of arterial stiffness in kidney patients one year after transplant: ...
    Medical condition: Patients with a kidney transplantation for more than one year and on cyclosporine
    Disease: Version SOC Term Classification Code Term Level
    20.0 10047065 - Vascular disorders 10047065 Vascular disorders SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2013-003195-12 Sponsor Protocol Number: CHUBX2012/29 Start Date*: 2013-10-01
    Sponsor Name:CHU de Bordeaux
    Full Title: A multicenter, two arms, randomized, open label clinical Phase IV study investigating the proportion of CMV seropositive kidney transplant recipients who will develop a CMV infection within the fir...
    Medical condition: CMV infection in CMV-seropositive de novo kidney transplant recipients receiving an immunosuppressive regimen.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2005-000517-36 Sponsor Protocol Number: CRAD001H2401 Start Date*: 2005-09-21
    Sponsor Name:Novartis Pharma Services AG
    Full Title: RESCUE Study (Certican in Liver Transplant Recipients with Renal Insufficiency) A 6-month, multicenter, randomized, open-label study of safety and efficacy of Certican-based regimen versus CNI-b...
    Medical condition: maintenance of liver transplant
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended) BE (Completed) ES (Completed) IT (Completed) FI (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2022-001417-39 Sponsor Protocol Number: FIBHGM-ECNC001-2022 Start Date*: 2023-05-18
    Sponsor Name:Fundación para la investigación biomédica del Hospital Gregorio Marañón (FIBHGM)
    Full Title: A phase IIb, double-blind clinical trial to compare the nephroprotection of cilastatin versus placebo in patients undergoing debulking surgery with intraoperative hyperthermic intraperitoneal chemo...
    Medical condition: Reduction of acute renal damage (days 1-7) (creatinine levels and KDIGO scale) in patients treated with CRS+HIPEC-cisplatin during the immediate postoperative period.
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-002212-32 Sponsor Protocol Number: GRAFT Start Date*: 2015-12-21
    Sponsor Name:Universität Leipzig
    Full Title: Granulocyte colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicentre randomized Trial
    Medical condition: Acute-on-chronic liver failure (ACLF)
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004871 10068752 Acute on chronic hepatic failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2005-003494-25 Sponsor Protocol Number: CAEB071A2203 Start Date*: 2006-08-30
    Sponsor Name:Novartis Pharma Services AG
    Full Title: 12-month open label, randomized, multicenter study evaluating efficacy, safety and tolerability of oral AEB071 plus tacrolimus (converted to myfortic after 3 months), vs. myfortic plus tacrolimus i...
    Medical condition: First evaluation of the efficacy and safety of AEB071 in its target indication: prevention of rejection in solid organ tranplantation. The study population will consist of a representative group of...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) IT (Completed)
    Trial results: View results
    EudraCT Number: 2008-003241-89 Sponsor Protocol Number: LCP-Tacro 3002 Start Date*: 2010-11-05
    Sponsor Name:LifeCycle Pharma A/S
    Full Title: A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study of the Efficacy and Safety of LCP-Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combi...
    Medical condition: Prevention of Acute Allograft Rejection in De Novo Adult Kidney Transplant Recipients
    Disease: Version SOC Term Classification Code Term Level
    12.1 10050436 Prophylaxis against renal transplant rejection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) SE (Completed) ES (Completed) IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-002223-32 Sponsor Protocol Number: E2007-0507 Start Date*: Information not available in EudraCT
    Sponsor Name:Charité Universitaetsmedizin
    Full Title: A multicentre, double-blind, randomised placebo-controlled trial of sodium bicarbonate to prevent acute kidney injury in patients undergoing cardiopulmonary bypass surgery.
    Medical condition: Cardiac surgical patients in whom the use of cardiopulmonary bypass is planned and having at least one ore more of the following risk factors for post-operative acute kidney injury • Age ≥ 70 years...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) IE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-005394-66 Sponsor Protocol Number: ESR-20-21070 Start Date*: 2022-02-21
    Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA SENESE
    Full Title: Effects of Dapagliflozin on cardiac deformation and clinical outcomes in heart failure with reduced and mildly reduced ejection fraction
    Medical condition: heart failure with left ventricular ejection fraction <50%
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004849 10024102 Left cardiac failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-000573-29 Sponsor Protocol Number: 20062007 Start Date*: 2009-10-16
    Sponsor Name:Amgen Inc
    Full Title: A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Using Cinacalcet to Correct Hypercalcemia in Renal Transplant Recipients With Autonomous Hyperparathyroid...
    Medical condition: Renal transplant recipients with hypercalcemia and autonomous hyperparathyroidism
    Disease: Version SOC Term Classification Code Term Level
    9.1 10020587 Hypercalcemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Prematurely Ended) FR (Completed) ES (Completed) IT (Completed) AT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-005310-19 Sponsor Protocol Number: PI-0697-2012 Start Date*: 2013-06-05
    Sponsor Name:FUNDACION PARA LA INVESTIGACIÓN BIOSANITARIA DE ANDALUCIA ORIENTAL_ FPA
    Full Title: Double-blind randomized clinical trial to evaluate the efficacy and safety of levosimendan as preischemic myocardial conditioner in pediatric cardiac surgery
    Medical condition: Children aged 1 month to 14 years in the health area of the province of Granada who will be undergoing heart surgery with a clinical high risk of developing acute heart failure after surgery, treat...
    Disease:
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-000348-17 Sponsor Protocol Number: CSL842_3001 Start Date*: 2017-11-17
    Sponsor Name:CSL Behring LLC
    Full Title: A Double-blind, Randomized-Withdrawal, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Human Plasma-Derived C1-esterase Inhibitor as Add-on to Standard of Care for the Treatment of ...
    Medical condition: Refractory AMR in adult renal transplant participants
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021428 - Immune system disorders 10023439 Kidney transplant rejection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) GB (GB - no longer in EU/EEA) DE (Prematurely Ended) ES (Prematurely Ended) NL (Prematurely Ended) FR (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-002208-17 Sponsor Protocol Number: DNB-001-CT002 Start Date*: 2007-08-14
    Sponsor Name:Danube Pharmaceuticals
    Full Title: A Phase IIa, Multi-Center, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of DNB-001 in Patients with Angina Pectoris and Moderate Chronic ...
    Medical condition: Angina pectoris and renal insufficiency whilst undergoing percutaneous coronary intervention (PCI).
    Disease: Version SOC Term Classification Code Term Level
    9.1 10063886 Renal insufficiency aggravated LLT
    9.1 10002384 Angina pectoris aggravated LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-001798-26 Sponsor Protocol Number: PROMETE Start Date*: 2014-02-12
    Sponsor Name:CHU DE POITIERS
    Full Title: A multicenter, open-label, Prospective, randomized parallel group Phase III study investigating the benefit on Renal function of a CNI-free regimen with MyfOrtic® (mycophenolate sodium) and Certica...
    Medical condition: Kidney transplantation
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-005335-83 Sponsor Protocol Number: OUS-PTx-01 Start Date*: 2013-04-05
    Sponsor Name:Oslo University Hospital Rikshospitalet
    Full Title: A Randomized Open-label Study: Efficacy and safety of basiliximab combined with tacrolimus, mycophenolate and low-dose corticosteroids vs thymoglobulin, tacrolimus, mycophenolate and high-dose co...
    Medical condition: The only indication for pancreas-transplantation (PTx) is advanced and/or badly controlled diabetes mellitus. Patients who have developed renal insufficiency due do diabetic nephropathy may be cand...
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10052278 Renal and pancreas transplant PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NO (Completed)
    Trial results: (No results available)
    EudraCT Number: 2018-002447-29 Sponsor Protocol Number: ERI-Study Start Date*: Information not available in EudraCT
    Sponsor Name:Medizinische Universität Wien, klinische Abteilung für Nephrologie und Dialyse
    Full Title: THE ENTERAL RESUSCITATION IN INTENSIVE CARE STUDY
    Medical condition: Patients on ICU require fluid substitution
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-015456-14 Sponsor Protocol Number: CAEB071A2214 Start Date*: 2010-01-11
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A partially blinded, prospective, randomized multicenter study evaluating efficacy, safety and tolerability of oral sotrastaurin plus standard or reduced exposure tacrolimus vs. myfortic plus tacro...
    Medical condition: Renal allograft transplantation
    Disease: Version SOC Term Classification Code Term Level
    12.0 10066543 Acute allograft rejection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: PT (Prematurely Ended) BE (Prematurely Ended) HU (Prematurely Ended) DE (Completed) SE (Prematurely Ended) NL (Prematurely Ended) DK (Completed) GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-001270-27 Sponsor Protocol Number: A6181061 Start Date*: 2005-08-17
    Sponsor Name:PFIZER LTD
    Full Title: A PHASE 2 EFFICACY AND SAFETY STUDY OF SU011248 ADMINISTERED IN A CONTINUOUS DAILY REGIMEN IN PATIENTS WITH CYTOKINE-REFRACTORY METASTATIC RENAL CELL CARCINOMA
    Medical condition: Histologically confirmed renal cell carcinoma with metastases with a component of clear (conventional) cell histology
    Disease: Version SOC Term Classification Code Term Level
    7,1 10038415
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2015-005346-58 Sponsor Protocol Number: RIMINI Start Date*: 2016-10-05
    Sponsor Name:Charité - Universitätsmedizin Berlin
    Full Title: Tacrolimus after rATG and infliximab induction immunosuppression (RIMINI)
    Medical condition: Rejection rate, graft loss or poor graft function defined as eGFR<40 ml/min in patients with kidney transplantation.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10021428 - Immune system disorders 10023439 Kidney transplant rejection PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) CZ (Completed) ES (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    «« First « Previous 2  3  4  5  6  7  8  9  10  Next» Last»»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri May 30 17:38:26 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA